News
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
16 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
16 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
11 Apr 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
SciSparc To Acquire AutoMax, A Strategic Leap Towards Industry Diversification
11 Apr 24
M&A, News
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
11 Apr 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
SciSparc Granted Canadian Patent #2984088 Titled "COMBINATIONS OF CANNABINOIDS AND N-ACYLETHANOLAMINES (FOR TREATMENT OF CONDITIONS SUCH AS MOVEMENT DISORDERS, BODY-WEIGHT GAIN, CONFUSION, DISORIENTATION, ANXIETY, AND PREVENTION OF PAIN)"
9 Apr 24
News, Legal
SciSparc- Clearmind Collaboration Evolves With New International Patent Application For Preventing And Treating Depression
27 Mar 24
Biotech, News, General
SciSparc Announces MitoCareX Unveils Groundbreaking Discovery Of Small Molecule Structure In Anti-Cancer Research
21 Mar 24
Biotech, News, General
SciSparc Bags Another Patent, Strengthening its Core Technology in Canada
18 Mar 24
Government, News, Regulations
SciSparc Achieves Major Milestone With First Patient Dosed In Autism Spectrum Disorder Clinical Trial
14 Mar 24
Biotech, News, General
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
12 Mar 24
Biotech, Cannabis, Psychedelics, Health Care, Top Stories, Exclusives
SciSparc and MitoCareX Bio Discover Potential Anti-Cancer Molecules Through Advanced Drug Screening
12 Mar 24
News
Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments
8 Mar 24
Cannabis, News, Health Care
SciSparc Has Received A Decision To Grant European Patent Number EP3484469 Titled "Compositions And Methods Of Potentiating Antimicrobials (Combined With Cannabinoids For Treatment Of Bacterial Infections)"
6 Mar 24
Biotech, News, General
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
4 Mar 24
Cannabis, Psychedelics, Financing, FDA, Legal, Management, Global
EXCLUSIVE: Psychedelic-Focused Firm Clearmind Medicine Submits Three New International Patent Applications For MDMA, Ibogaine And Ketamine Compounds
27 Feb 24
Biotech, Cannabis, News, Psychedelics, Health Care, Market-Moving Exclusives, Exclusives, Movers, General
Next-Gen Psychedelics Companies SciSparc And Clearmind Collaboration File 3 Patents
21 Feb 24
Cannabis, News, Psychedelics, Markets
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock?
20 Feb 24
Cannabis, News, Movers
Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
20 Feb 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
SciSparc Has Initiated Patient Recruitment For Its Clinical Trial In Children Suffering From Autism Spectrum Disorder At Soroka Medical Center In Israel
29 Jan 24
Biotech, News, Health Care, General
Press releases
SciSparc to Acquire AutoMax
11 Apr 24
M&A, News, Press Releases
Clearmind Medicine Announces International Patent Application for Preventing and Treating Depression
27 Mar 24
Press Releases
SciSparc- Clearmind Collaboration Evolves with New International Patent Application for Preventing and Treating Depression
27 Mar 24
Press Releases
SciSparc: MitoCareX Unveils Groundbreaking Discovery of Small Molecule Structure in Anti-Cancer Research
21 Mar 24
Health Care, Press Releases
SciSparc Granted Another Patent, Strengthening its Core Technology in Canada
18 Mar 24
News, Legal, Press Releases
SciSparc Achieves Major Milestone with First Patient Dosed in Autism Spectrum Disorder Clinical Trial
14 Mar 24
Press Releases
SciSparc: MitoCareX Reveals Promising Results with Discovery of Novel Anti-Cancer Small Molecule Structure
12 Mar 24
Health Care, Press Releases
SciSparc Announces Enrollment of First Patient for its Clinical Trial for Children with Autism Spectrum Disorder
8 Mar 24
Health Care, Press Releases
SciSparc Granted Patent for Core Technology in Multiple Jurisdictions in Europe
7 Mar 24
News, Legal, Press Releases
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
6 Mar 24
Press Releases
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
29 Feb 24
Health Care, Press Releases
Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds
27 Feb 24
News, Legal, Press Releases
SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds
27 Feb 24
News, Legal, Press Releases
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
29 Jan 24
Health Care, Press Releases
SciSparc Ltd. Announces $20 Million Standby Equity Purchase Agreement
24 Jan 24
News, Contracts, Press Releases